重新利用线粒体向治疗脏疾病的治疗方法
Austin D Thompson1, Paul Victor Santiago Raj2, Natalie E Scholpa3
1Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA; Southern Arizona VA Health Care System, Tucson, Arizona, USA; Southwest Environmental Health Science Center, University of Arizona, Tucson, Arizona, USA.
线粒体功能障碍驱动脏疾病的进展. 重用针对线粒体的药物提供了一个有希望的,具有成本效益的策略,以恢复功能并加速恢复.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 线粒体生物学 线粒体生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脏是高度代谢活跃的器官,需要大量的腺三酸盐 (ATP) 来起作用.
- 靠近管状细胞富含线粒体,以满足高能耗需求.
- 线粒体功能障碍是病的发展和进展的关键因素,导致细胞损伤和纤维化.
研究的目的:
- 为了提供线粒体功能障碍在损伤和疾病的概述.
- 突出针对线粒体的治疗方法,具有对脏疾病的重用潜力.
- 讨论药物用于治疗病的重用药物的优点.
主要方法:
- 在病理学中对线粒体功能障碍的文献综述.
- 对目前针对线粒体向治疗的研究进行分析.
- 对脏疾病的药物重用策略的评估.
主要成果:
- 线粒体功能障碍有助于氧化还原失衡,生物能学受损,氧化应激和脏炎症.
- 几种针对线粒体的药物显示出治疗脏疾病的潜力.
- 与新药发现相比,药物重新定位提供了诸如降低成本和开发时间等优势.
结论:
- 线粒体功能障碍是脏疾病的关键治疗标.
- 重用现有药物提供了一种可行的和有效的方法来开发用于脏疾病的新疗法.
- 向线粒体有望恢复功能并促进恢复.
更多相关视频
09:00Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
Published on: March 27, 2018
08:06Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions
Published on: July 2, 2020
相关概念视频
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
